Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
24.10
Dollar change
+0.24
Percentage change
1.01
%
IndexRUT P/E- EPS (ttm)-0.09 Insider Own14.24% Shs Outstand77.13M Perf Week-1.95%
Market Cap1.86B Forward P/E9.58 EPS next Y2.52 Insider Trans-0.06% Shs Float66.18M Perf Month-9.74%
Income-6.54M PEG- EPS next Q0.85 Inst Own92.83% Short Float6.20% Perf Quarter37.17%
Sales1.56B P/S1.19 EPS this Y-20.92% Inst Trans-0.73% Short Ratio4.24 Perf Half Y-21.75%
Book/sh19.73 P/B1.22 EPS next Y2.66% ROA-0.17% Short Interest4.10M Perf Year-41.12%
Cash/sh3.60 P/C6.70 EPS next 5Y-3.71% ROE-0.42% 52W Range16.81 - 45.42 Perf YTD-44.66%
Dividend Est.- P/FCF48.89 EPS past 5Y3.10% ROI-0.23% 52W High-46.94% Beta1.16
Dividend TTM- Quick Ratio0.73 Sales past 5Y1.17% Gross Margin56.26% 52W Low43.41% ATR (14)0.88
Dividend Ex-Date- Current Ratio1.20 EPS Y/Y TTM-107.27% Oper. Margin9.92% RSI (14)57.56 Volatility3.27% 3.60%
Employees5329 Debt/Eq1.31 Sales Y/Y TTM1.45% Profit Margin-0.42% Recom3.23 Target Price26.00
Option/ShortYes / Yes LT Debt/Eq0.90 EPS Q/Q-157.27% Payout0.00% Rel Volume0.43 Prev Close23.86
Sales Surprise1.34% EPS Surprise5.10% Sales Q/Q-0.41% EarningsNov 04 BMO Avg Volume967.53K Price24.10
SMA200.90% SMA5013.10% SMA200-8.94% Trades Volume415,162 Change1.01%
Date Action Analyst Rating Change Price Target Change
Dec-02-24Initiated Morgan Stanley Underweight $25 → $20
Oct-07-24Upgrade BTIG Research Sell → Neutral
Jul-30-24Downgrade Citigroup Neutral → Sell $30 → $23
Jul-30-24Downgrade BTIG Research Neutral → Sell $22
May-07-24Downgrade Wells Fargo Overweight → Equal Weight $45 → $25
May-07-24Downgrade Oppenheimer Outperform → Perform
Apr-03-24Upgrade Citigroup Sell → Neutral $38
Dec-05-23Upgrade Wells Fargo Equal Weight → Overweight $40 → $49
Nov-14-23Initiated CL King Buy $50
Aug-24-23Downgrade Morgan Stanley Equal-Weight → Underweight $44
Dec-04-24 11:30AM
Nov-13-24 04:10PM
Nov-06-24 06:31AM
Nov-05-24 02:03AM
12:28AM
12:18AM Loading…
12:18AM
Nov-04-24 01:12PM
09:30AM
07:15AM
06:10AM
06:03AM
06:00AM
Nov-01-24 09:04AM
Oct-14-24 08:00AM
Sep-11-24 02:30AM
04:01PM Loading…
Sep-04-24 04:01PM
10:32AM
Aug-21-24 04:15PM
Jul-30-24 12:49PM
03:29AM
Jul-29-24 12:23PM
09:30AM
07:15AM
06:13AM
06:00AM
Jul-22-24 10:01AM
Jul-19-24 08:34AM
Jul-17-24 08:00AM
Jul-16-24 09:14AM
Jul-15-24 08:00AM
08:00AM Loading…
08:00AM
Jun-07-24 06:09PM
Jun-05-24 11:30AM
May-30-24 05:39PM
May-28-24 01:34PM
04:22AM
May-17-24 07:54AM
May-13-24 04:30PM
12:07PM
May-08-24 12:15AM
May-07-24 11:33AM
11:10AM
08:02AM
07:27AM
07:19AM
03:02AM
01:45AM
May-06-24 01:23PM
12:35PM
12:35PM
10:53AM
09:30AM
06:29AM
06:10AM
06:00AM
Apr-30-24 04:20PM
Apr-18-24 05:24PM
Apr-17-24 10:01AM
Apr-09-24 08:41AM
Apr-01-24 04:15PM
Mar-29-24 11:30AM
Mar-13-24 08:17AM
Mar-12-24 12:04PM
Mar-11-24 08:30AM
Feb-29-24 11:46AM
10:43AM
05:52AM
Feb-28-24 10:46PM
09:30AM
07:15AM
06:32AM
06:28AM
06:25AM
06:00AM
06:00AM
Feb-27-24 05:03AM
Feb-26-24 09:15AM
Feb-21-24 10:00AM
Feb-07-24 09:15AM
Jan-20-24 03:19PM
Jan-10-24 07:13AM
Jan-05-24 04:30PM
Dec-14-23 11:14AM
Dec-13-23 06:15AM
06:04AM
Dec-12-23 12:00PM
Nov-24-23 11:31AM
Nov-08-23 08:00AM
Oct-26-23 10:52AM
08:20AM
Oct-25-23 09:30AM
08:06AM
07:15AM
06:13AM
06:00AM
Oct-13-23 11:40AM
Oct-11-23 06:53PM
Oct-10-23 05:38PM
Oct-05-23 08:25AM
Oct-04-23 08:00AM
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schwartz EricEVP, Chief Legal Officer & SecDec 03 '24Sale24.594,070100,10259,511Dec 04 04:32 PM
Schwartz EricOfficerDec 03 '24Proposed Sale24.594,070100,102Dec 03 05:30 PM
McBreen Michael J.EVP & President, CSSDec 02 '24Sale24.161,70041,06456,182Dec 03 04:19 PM
De Witte JanPresident & CEONov 01 '24Option Exercise0.009,814028,164Nov 04 04:33 PM
Mosebrook JeffreySVP, Fin & Princ Acct OfficerAug 19 '24Sale21.581,19125,70136,088Aug 20 04:22 PM
ESSIG STUARTExec. Chairman of the BoardMay 23 '24Buy28.4952,6411,499,979487,922May 24 04:08 PM
HILL BARBARA BDirectorMay 21 '24Buy27.4036,350995,81636,350May 22 04:09 PM
De Witte JanPresident & CEOMar 11 '24Option Exercise0.00205018,555Mar 13 04:30 PM
De Witte JanPresident & CEOMar 10 '24Option Exercise0.00346018,696Mar 12 05:12 PM
Singh HarvinderEVP & PRESIDENT, INTERNATIONALMar 10 '24Option Exercise0.001,17901,179Mar 12 05:10 PM
DAVIS ROBERT T. JR.EVP & President, TTMar 06 '24Option Exercise32.598,736284,66358,241Mar 08 04:22 PM
DAVIS ROBERT T. JR.EVP & President, TTMar 06 '24Sale36.598,348305,49249,893Mar 08 04:22 PM
De Witte JanPresident & CEOJan 18 '24Option Exercise0.00597018,947Jan 19 04:43 PM